• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

CLIA - Clinical Laboratory Improvement Amendments

  • Print
  • Share
  • E-mail
-
1 to 4 of 4 Results
Document Number CR260192
Results per Page

New Searchexport reports to excelExport to Excel | HelpHelp
Document Parent Analyte Analyte Specialty Complexity Effective Date
Roche Diagnostics, cobas pro integrated solutions, cobas c 703  {Tina-quant Alpha-1-Acid Glycoprotein Gen.2} (serum and plasma samples only)
CR260192 K060373 Alpha-1-acid glycoprotein (orosomucoid) General Immunology MODERATE 05/04/2026
Roche Diagnostics, cobas pro integrated solutions, cobas c 703  {Tina-quant Beta-2-Microglobulin (serum/plasma)} (serum and plasma samples only)
CR260192 CR260192 Beta-2 microglobulin General Immunology MODERATE 05/04/2026
Roche Diagnostics, cobas pro integrated solutions, cobas c 703  {Tina-quant Beta-2-Microglobulin (urine)} (urine sample only)
CR260192 CR260192 Beta-2 microglobulin General Immunology MODERATE 05/04/2026
Roche Diagnostics, cobas pro integrated solutions, cobas c 703  {Tina-quant Antistreptolysin 0} 
CR260192 CR260192 Anti-streptolysin O (ASO) General Immunology MODERATE 05/04/2026

-
-